Log In
BCIQ
Print this Print this
 

MN-029

Also known as: MN029

  Manage Alerts
Collapse Summary General Information
Company Angiogene Pharmaceuticals Ltd.
DescriptionSecond-generation tumor vascular targeting agent
Molecular Target Tubulin
Mechanism of ActionMicrotubule polymerization inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerMediciNova Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today